ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Major Changes Being Considered By NCI For FCRA

April 14, 1978

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

Mail Mixup Delays July 23 Issue

August 6, 1976

Army Breast Cancer Program Seeks Grants Applicants

May 17, 1996

DeVita Losing Patience, Responds To Powers Letter

May 6, 1983

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

December 11, 1992